Current stock page

Catalysts

BBIO Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

BBIOBridgeBio Pharma, Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

NeutralEdge 7/10
$78.30+$0.13 (+0.17%)

Latest quote

  • Momentum
    69
  • Value
    55
  • Quality
    66
  • Risk resilience
    62
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 23, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 64/100

Momentum 69/100 and sentiment — before the next covered event.

Recent coverage
2 articles

Updated Nov 15, 2026 · Sentiment 10.55%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 69/100AIQ Edge 7/10 Above Peers
Beat rate
25%
2 of 8 reported periods
Average surprise
-13.4%
Across covered historical reports
Latest result
+22.5%
Oct 29, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 29, 2026—-$0.54-$0.42+22.5%$293.47M$353.17M
Aug 10, 2026—-$0.58-$0.78-35.5%$220.91M$243.68M
May 7, 2026—-$0.68-$0.84-23.8%$178.07M$194.52M
Feb 24, 2026—-$0.71-$1.00-40.2%$146.84M$154.18M
Oct 29, 2025—-$0.88-$0.95-8.0%$148.15M$120.7M
Aug 5, 2025—-$0.83-$0.95-14.5%$108.13M$110.57M
Apr 29, 2025—-$1.00-$0.88+12.0%$68.41M$116.63M
Feb 20, 2025—-$1.09-$1.31-20.2%$4.04M$5.88M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
19
Buy
3
Hold
12-month analyst target
$111.17
+41.98% versus current price
Based on 22 analyst observations. Targets are estimates, not predictions.
Low target
$87.00
+11.11% vs latest price
Average target
$111.17
+41.98% vs latest price
High target
$156.00
+99.23% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 23, 2027

Next known earnings or reporting date.

EPS estimate-$0.59

Current analyst expectation for the upcoming report.

Revenue estimate$310.85M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score69

Where event reaction would show up first.

AIQ score64/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
22
Average target
$111.17
Target upside
41.98%
Target range
$87.00 - $156.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
1
Negative
0
seekingalpha.com · Oct 30, 2026

BridgeBio Pharma, Inc. (BBIO) Q3 2026 Earnings Call Transcript

BridgeBio Pharma, Inc. (BBIO) Q3 2026 Earnings Call October 29, 2026 4:30 PM EDTCompany ParticipantsChinmay Shukla - Senior Vice President of Strategic...

gurufocus.com · Oct 21, 2026

BBIO Maintained by Morgan Stanley -- Price Target Lowered to $87

BridgeBio Pharma Analyst Rating Update On %B %d, %Y, Morgan Stanley has maintained its Overweight rating for BridgeBio Pharma Inc (BBIO) while adjusting the

Open full news and sentiment

BBIO Catalysts FAQ

What are the next catalysts for BBIO stock?

BBIO's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move BBIO stock?

Upcoming events that could move BBIO include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could BBIO's next earnings report affect the stock?

BBIO's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive BBIO stock higher?

BBIO could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt BBIO stock?

BBIO could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.